Glioma-Associated Oncogene-1 Expression in Basal Cell Carcinoma and Its Histologic Mimics

Area of Science:

• Dermatopathology
• Oncology
• Molecular Biology

Background:

• Basal cell carcinoma (BCC) is the most common skin cancer.
• Histologic mimics of BCC present diagnostic challenges.
• Immunohistochemical stains can aid diagnosis but have interpretation variability.

Purpose of the Study:

• To evaluate the utility of immunohistochemical staining for glioma-associated oncogene-1 (Gli-1) in differentiating BCC from its mimics.
• To assess Gli-1 expression patterns in various skin tumors.

Main Methods:

• Immunohistochemical staining for Gli-1 was performed on 130 diverse skin tumors, including BCCs, basaloid squamous cell carcinomas, trichoepitheliomas, Merkel cell carcinomas, sebaceous carcinomas, cylindromas, spiradenomas, and adenoid cystic carcinomas (AdCC).
• Staining intensity (0, 1+, 2+, 3+) and distribution (diffuse, multifocal, focal) were analyzed.

Main Results:

• Strong, diffuse Gli-1 expression was observed in all basal epidermal-type tumors (BCC, trichoepithelioma, basaloid squamous cell carcinoma).
• Merkel cell carcinomas showed no cytoplasmic Gli-1 expression.
• Sebaceous carcinomas exhibited weak or negative Gli-1 staining.
• Adnexal tumors (cylindroma, spiradenoma, AdCC) displayed variable Gli-1 staining patterns.

Conclusions:

• Gli-1 expression is consistent in basal epidermal-type tumors, potentially limiting its use in distinguishing within this group.
• Gli-1 may help differentiate basal epidermal-type tumors from adnexal lesions, particularly sebaceous carcinoma, cylindroma, spiradenoma, and AdCC.
• Absence of cytoplasmic Gli-1 staining is crucial for excluding Merkel cell carcinoma.